balance sheet versus amd. deal going to be enough to put them in the same conversation? >> this is not going to be enough, but this is a step in the right direction and it's a recognition by amd that we're really moving from chips to systems and they're woefully behind nvidia systems development like dgx like we see there. this is a step in the right direction and a catch-up play from amd. >> is this going to be enough of a catch-up play where amd can get close to the same kinds of returns that we've seen medium to longer term than nvidia. i guess, in other words, i would just ask, could nvidia be the amd story or the amd and the nvidia story of the next five to ten years? >> amd could be, but nvidia has such a lead here, particularly in the software and in kuda that it's unlikely, but amd can have a piece of the pie here overall. we think they could ultimately have ten or 15, perhaps even 20% of this market, but in order to do so they need a rack scale system design. really think about it this way. we're not

. indie threat then the shorter ones from intel and amd.- from intel and amd._ from intel and amd. we will have to live there. _ from intel and amd. we will have to live there. thank - from intel and amd. we will i have to live there. thank you. you are welcome. if you are missing the olympics, don't worry. later today the paralympic games officially get under way. the event spans 11 days of elite competition across 22 sports, featuring 4,400 athletes from 128 nations. while many cited the london 2012 games as a watershed moment for the paralympics, can paris 2024 raise the bar forfairer sponsorship in the paralympic games? nicola kemp is editorial director at creativebrief, a marketing intelligence platform. we asked her if the paralympicgames offer a special kind of opportunity for brands? really interesting because there's a huge marketing opportunity here. there's a real sponsorship gap. so this is an opportunity that crosses sectors. you do tend to see the same core sponsors as you do in the olympic games. so we see a lot of automotive brands, like toyota,

so we like amd. there are many reasons to like amd.re's a chance for them to gain share from intel in the cpu market. they're also participating in the ai market which we think could grow 30% to 50% a year. on this specific deal, we think it will take time. >> is that necessarily a bad thing? in that if you already like amd and think they have decent tailwinds, this is perhaps another one to come in a few quarters down the line, as an investor, should you look atthosis comments from you skeptically and say, well, this is a longer way out benefit, or is it more bullish saying okay, here's another boost potentially a few quarters down the line? >> sure, no, i do think that it is a positive, back to the point of when does it start to matter to numbers in a tangible way. if you take the ai market as a whole, today nvidia is about 70%, 75% of it. if you take all the custom chips from broadcom and marvell, that's another 20%. amd is fighting for the number three position in the market. that's the remaining 10% of the market and they're about

ian king covers amd, nvidia, which is the elephant in the room amd is trying to tackle. >> that is absolutely right. nvidia has made it easier for all of its big customers to adopt these systems. if you need a server, we will give you server design, we will bundle everything together and do a lot of engineering for you. amd is saying, we can do that too. here are the capabilities we have taken hold of. ed: these numbers we have used before. nvidia will do $100 billion this year. on amd's side, m&a is being a tool and a theme. what are they trying to add? ian: it is all of these engineering capabilities that go beyond core competence. designing chips that we will give you the software, the models, the designs of the servers themselves, we will give you these things, we will help you to adopt our chips. it is a facilitator, if you like. it is what they are doing. ed: systems vendor. what does that mean in reality? in the real world when we talk about training ai models with high-performance gpu's? ian: you have to think about a data center is not a room full of computers, but as a computer. it

amd ce

and that's difficult for amd to compete with. amd, understand, is a much smaller company. is moves to compete with stock ware and on the open source stack. you have seen the acquisition it made a couple weeks ago. that's to try to improve it's sort of wax scale expertise. so i think it is keeping pace with nvidia, but at the moment, nvidia is still the go-to. of course, the other outside contender is owned and begun by the cloud service providers, the chips that they use and some of the microsoft products as well. so, you know, it's not a complete moat, but i would actually note that nvidia's mode has gotten stronger, not weaker. >> ben, we appreciate the conversation. global tnt analyst. >>> and moving on openai, also tox on a funding round that would value the a.i. startup at more than $100 billion. cnbc has learned one source with knowledge the matter was told the round would be earned by thrive capital. "the wall street journal" has reported that microsoft which is openai's bigger backer will also participate in the round. openai and microsoft failed to decline. what's

with wet amd, i t only losing my sight, but my time to enjoy it.ut now, i can open up my world with vabysmo. (♪) vabysmo is the first fda-approved treatment for people with wet amd that improves vision and delivers a chance for up to 4 months between treatments, so i can do more of what i love. (♪) (♪) vabysmo works differently, it's the only treatment designed to block 2 causes of wet amd. vabysmo is an eye injection. don't take it if you have an infection, active eye swelling, or are allergic to it. treatments like vabysmo can cause an eye infection or retinal detachment. vabysmo may cause a temporary increase in eye pressure after receiving the injection. there is an uncommon risk of heart attack or stroke associated with blood clots. severe swelling of blood vessels in the eye can occur. most common eye side effects were cataract and broken blood vessels. open up your world with vabysmo. a chance for up to 4 months between treatments with vabysmo. ask your doctor. [ distorted ] i just think everyone should know there's an insurance company out

there's another company, amd.l be 70% of the market, and nvidia is suited for both. they can do that just as well. amd brings better value proposition but are looking at the performance level, which they are trying to bring the level up. it will take them a year, year and a half to do that. >> right. thank you so much for being on with us today. nvidia shares down more than 3%. as we head to break, here's our roadmap for the rest of the hour. it's not just nvidia on the move today. shares of salesforce are rallying. what investors need to know. >>> and then crowdstrike. "squawk on the street" back after this. you founded your kayak company because you love the ocean- not spreadsheets. you need to hire. i need indeed. indeed you do. indeed instant match instantly delivers quality candidates matching your job description. visit indeed.com/hire craig here pays too much for verizon wireless. so he sublet half his real estate office... matching your job description. [ bird squawks loudly ] to a pet shop. meg's moving c

from the sector perspective, we had amd earlier in the week and amd gave us pretty good results.season started off with taiwan semiconductor. they had good results and good guide. i'm more concerned about intel than i am in the space. >> what exactly stood out to you? we know the misses and the headline numbers that are driving a lot of this, but what is it you think is driving a 22% drop in a dow component stock? >> i think it is the sharp drop they saw in gross margins and to some extent, the lower revenue guide, but it's in part, intel is going through the huge transformation. so when they struggle to understand what's going on in the current environment, it makes it a little bit harder to believe that they have a great understanding of what's going to be happening three or four or five years out which is when the model gets a lot more optimistic. >> do you feel as though this is one of those opportunities for investors to take a hard look at whether or not the turn around story will happen in some medium-to medium-ish time span and could it be an opportunity for investors to

the amd ceo says this allows amd to test, roll out a.i.lly fast and at the scale cloud computing giants like microsoft require. you can see nvidia is down, micron, my eyes are failing me here. they're all lower this is a challenge coming from amd. typically when one company buys another company the shares of the company who is buying the company go down. that is what we're seeing. amd discuss turned higher. just turned higher. larry: see what you did, lauren, see what you did. move on to different market sector, retailers. tell me. stuart: tell me more about the retailers. how they're doing. >> lowe's, target, can they fire on all cylinders the way walmart did last week, right. walmart profits are expected to rise 21%. macy's department store struggling shares down 12% this year. can they turn this around? this profit is about to go up 16% but revenue is expected to go down. everybody is huntings for a bargain. tjx, parent company of tj maxx, home goods. that is a winner so far this year. they will be reporting wednesday morning. larry: re

on amd's part.hey are really the number two provider and they need to have this increased data center capability to be more competitive going forward, so we like amd, have for a long time as you know and the point of the matter is this is amd strategic entry to begin to challenge nvidia. liz: well we're looking at a lot of challenges from competitors and rivals in the chip space. this is what capitalism is all about. it's great to see you dryden. robert, thank you very much. i know it's loud there but thanks for putting up with it. we appreciate it. we've got some changes at the top for cosmetics giant estee lauder. is the stock's reaction pretty? find out when we come back. the "clayman countdown" has so much more on the markets and we've got some breaking news on cease-fire talks in israel. and tomorrow, singer songwriter and now will i am joins us here first on fox business. he has founded a.i. company fyi and will unveil his app right here that he says will turbo charge your creativity by turnin

it's amd hands down. when you think about it, arm is more of a play. it's kind of still a relic of that meteoric rise that it had earlier in the year and hasn't really come down from. you know, micron is kind of more in the memory space, much cheaper stock but not really in direct competition. it's amd. why? also from a liquidity standpoint, it can handle those flow of funds. people are looking for a new story if nvidia starts to erode or this market share story we have starts to wain, it's going to be amd who's probably chipping into that share. that's a lot of stock a lot of people have wanted to see work better than it has. the stocks with well over 200 back in march, numbers that were lower than here. it just kind of came down because funds flowed through nvidia. as that starts to unwind, we think amd is the larger beneficiary. >> thanks for the conversation. that's josh koren, founder and ceo after musketeer. >>> for more on the pressure for nvidia to perform, you can check out our earnings preview at cnbc.com. that story is live for you right now

. >>> amd in focus signed a deal to acquire zt systems in a cash and stock transaction.his comes to help speed up the data center chips and challenging nvidia in the semiconductor market. seema modi files this report. >> reporter: amd ceo lisa su joined cnbc today and said this will help own more infrastructure which nvidia already does. zt systems is an a.i. service provider that generating $10 billion in sales. with this deal, amd will bring in 1,000 engineers with expertise and plans to find a buyer for the manufacturing business. zt competes with super micro. amd is projecting the data center market will grow in the coming years which is one of the reasons it is making the acquisition. zt systems has the second acquisition this year. both transactions are seen as a way to increase roads for amd and help it better compete with the likes of nvidia. for cnbc business news, i'm seema modi. >>> more m&a is in the market according to kepler. this is a week after kellanova announced they are set to acquire pringles maker for $36 billion. it is 16 times ebitda. we have john

you're not going to dislodge what amd has done. amd is winning the pc war. communicated my belief that the credit risk to the government, to the chips, is not great, but they do have partners. and they have brookfield, which is really interesting, and apollo, so they've got people to lean on, so i'm not saying, listen, it's that dire. but i'm not changing my view that this is not the intel. read between the lines. it wasn't the starbucks of old. >> speaking of challenge names that have come back from the lows this morning, e.l. was down six at one point on earnings. >> we're bolting from the last bit of e.l. that we have this morning, estee lauder. this is fabrizio, who's retiring at the end of the year. the number of cuts have been unbearable, five going to three and change. there's a nice jeffries piece out about it. this is a -- i'm going to -- look, i don't want to minimize tragedy, because tragedy is horrible, but financial. this thing has been one of the worst performers, and a lot of it is china, but a lot of it is -- as much as i like fabrizio, there

if you have wet amd, you never want to lose sight of the things you love.hould stand the test of time. long-lasting eylea hd could significantly improve your vision. more people on eylea hd had no fluid in the retina, compared to those on eylea at 4 months. eylea hd is the only wet amd therapy that helped 8 out of 10 people go up to 4 months between injections, after 3 initial monthly treatments. if you have an eye infection, eye pain or redness or allergies to eylea hd, don't use. eye injections like eylea hd may cause eye infection, separation of the retina, or rare but severe swelling of blood vessels in the eye. an increase in eye pressure has been seen there is an uncommon risk of heart attack or stroke associated with blood clots. the most commons side effects were blurred vision, cataract, corneal injury and eye floaters. and there's still so much to see. if you are on eylea or a similar type of treatment, ask your retina specialist about eylea hd today for the potential for fewer injections. (♪) (♪) voltaren... for long lasting arthritis pain relief

(♪♪) with wet amd, i worry i'm not only losing my sight, but my time to enjoy it. with vabysmo. (♪♪) vabysmo is the first fda-approved treatment for people with wet amd that improves vision and delivers a chance for up to 4 months between treatments, so i can do more of what i love. (♪♪) (♪♪) vabysmo works differently, it's the only treatment designed to block 2 causes of wet amd. vabysmo is an eye injection. don't take it if you have an infection, active eye swelling, or are allergic to it. treatments like vabysmo can cause an eye infection or retinal detachment. vabysmo may cause a temporary increase in eye pressure after receiving the injection. there is an uncommon risk of heart attack or stroke associated with blood clots. severe swelling of blood vessels in the eye can occur. most common eye side effects were cataract and broken blood vessels. open up your world with vabysmo. a chance for up to 4 months between treatments with vabysmo. ask your doctor. with claritin, relieving your allergies is a walk in the park. get fast, all-day relief of your worst allerg

. >> i think that's better than >> i think that's better than actual c (♪) with wet amd, i worry i'my losing my sight, but my time to enjoy it. but now, i can open up my world with vabysmo. (♪) vabysmo is the first fda-approved treatment for people with wet amd that improves vision and delivers a chance for up to 4 months between treatments, so i can do more of what i love. (♪) (♪) vabysmo works differently, it's the only treatment designed to block 2 causes of wet amd. vabysmo is an eye injection. don't take it if you have an infection, active eye swelling, or are allergic to it. treatments like vabysmo can cause an eye infection or retinal detachment. vabysmo may cause a temporary increase in eye pressure after receiving the injection. there is an uncommon risk of heart attack or stroke associated with blood clots. severe swelling of blood vessels in the eye can occur. most common eye side effects were cataract and broken blood vessels. open up your world with vabysmo. a chance for up to 4 months between treatments with vabysmo. ask your doctor. time to press rewind with... neutrog

. (♪♪) with wet amd, i worry i'm not only losing my sight, but my time to enjoy it.smo. (♪♪) vabysmo is the first fda-approved treatment for people with wet amd that improves vision and delivers a chance for up to 4 months between treatments, so i can do more of what i love. (♪♪) (♪♪) vabysmo works differently, it's the only treatment designed to block 2 causes of wet amd. vabysmo is an eye injection. don't take it if you have an infection, active eye swelling, or are allergic to it. treatments like vabysmo can cause an eye infection or retinal detachment. vabysmo may cause a temporary increase in eye pressure after receiving the injection. there is an uncommon risk of heart attack or stroke associated with blood clots. severe swelling of blood vessels in the eye can occur. most common eye side effects were cataract and broken blood vessels. open up your world with vabysmo. a chance for up to 4 months between treatments with vabysmo. ask your doctor. today's biggest feat wasn't making costumes for the school play. or locking in an appointment... and actually getting

against them is amd. i think they can make all the chips in the world and yesterday leslie was on, i know the stock is down badly. when i listened to that call, i don't buy the going concern. you know i think it's going lower but when you listen to that call all you think of, carl, is yesterday renee haass in great shape. the day before lisa suh in great shape doing well. this company may be carrying. not carrier. >> carrion, c-a-r-r-i-o-n. >> i didn't mention maga. >> many years as we've mentioned of mismanagement, poor decisions in terms of -- then execution as well. >> you know i thought -- i asked secretary raimondo, is it safe to do business with intel, secretary of commerce. i think everyone felt it was safe and listening to the call thinking, there's a moment, this is the moment where they don't have the business. and the moment where amd is calling michael dell, michael dell is calling amd, enrique, he's calling lisa, hp. >> after a week where we got our guidance and western dig guidance and intel

taylor: if i missed the nvidia rally and get in the a, space and i take a look at amd.l me that's a good move or is amd so far behind like everyone else and it's really nvidia versus everyone else or does amd have a shot to close the gap if it only take as couple year s? >> taylor: yeah, taylor, our market indication and intention we built shows the space is growing mid double digits for the half decade and that's longer than that. the acquisitions in software and rock scale manufacturing and developing is a series made and made made is a competitor and it's a slow build. it's such a large install base and we know that all the cloud company are building own chips and intel going to get into the fray of building competitive parts and i think you can invest in many companies and understand horizon and it's right now this instant cap x build out and hundreds of billions being spent and near term and nvidia is the company to fulfill most of that demand but ai is not going to be done in two, three, four quarters and it's actually in it is early innings. taylor: on that note

. (♪♪) with wet amd, i worry i'm not only losing my sight, but my time to enjoy it. up my world with vabysmo. (♪♪) vabysmo is the first fda-approved treatment for people with wet amd that improves vision and delivers a chance for up to 4 months between treatments, so i can do more of what i love. (♪♪) (♪♪) vabysmo works differently, it's the only treatment designed to block 2 causes of wet amd. vabysmo is an eye injection. don't take it if you have an infection, active eye swelling, or are allergic to it. treatments like vabysmo can cause an eye infection or retinal detachment. vabysmo may cause a temporary increase in eye pressure after receiving the injection. there is an uncommon risk of heart attack or stroke associated with blood clots. severe swelling of blood vessels in the eye can occur. most common eye side effects were cataract and broken blood vessels. open up your world with vabysmo. a chance for up to 4 months between treatments with vabysmo. ask your doctor. >> major: u.s. health officials gave an update today on the listeria outbreak linked to boar's h

amd, ceo, abc, de -- amd ceo lisa su. a lot of letters. like alphabet soup.hair and makeup product company estee lauder shares down following fiscal year results. forecast well below analysts estimates that cited a more tempered wormens in china. hear that a lot. the company's long-time ceo is retiring. and the japanese owner of 7-eleven received a preliminary takeover offer from a canadian operator. circle k convenience store. the proposal. not exactly clear. biggest to ever face a foreign buyout. >> makes sense, too. >> absolutely. under 90 minutes to go before the opening bell on wall street. contessa brewers joins us. >> personal computers in focus. morgan stanley downgrading hp2 to equal weight leaving the price target unchanged at $37 saying all upside are predicted last year are bakeded into the share price and sees slightly weaker than expected demand in restocking personal computers and back-to-school sales. though morgan stanley remains bull number general or pcs. sharing moving in the extending trading down 2%. burlington stores, upgrade from h h h

an easy name to mention is amd, they i name to mention is amd, they have their own product coming outai forecast up to 4.5 billion which is great when you compare that you nvidia, probably in the hundred billion dollar range, it is just a contest at this point. intel does not have a competing product either. this is nvidia's world and we're just living in. at the same time key customers, the hyper scale is like amazon and google and microsoft, they are spending billions of dollars on nvidia products and frankly they cannot be happy around everything that nvidia has over them, so they are developing their ownerships. for cost reasons and for nvidia reasons and i think that is a big competition that is coming down the line. having said that, nvidia has 95% of the market share today and i cannot imagine nvidia losing share, perhaps 90 or 80, but they will dominate this landscape for multiple years.— dominate this landscape for multiple years. taking a step back and look— multiple years. taking a step back and look at _ multiple years. taking a step back and look at technology, | multiple

i think amd just got the silver medal in a.i. chips.nd the gold medalist nvidia but they cemented their second tier, their number two status if you ask me. stuart: an olympic -- lauren: silver medalist. stuart: that really worked. now show me nvidia. they're down a little this morning but way up from their low, right? lauren: yeah, 30% from the low august 7. 31% to be exact. so this is their first decline in seven days. the next catalyst for nvidia is earnings which are due the end of the month, august 28. since the august lows, so nvidia is up almost 31%. super micro is up 26%. marvel technology 25%, and micron 24%, so if you had the stomach to get in then, you made a lot of money and its only been a couple of days. stuart: i missed them all. all right, lauren, thank you. let's check that big board. turning a little further south, now we're down about 80 points but look at the level, 40, 800. there are dow winners and we'll put them on the screen for you. right now, the leading winner is merck, nike, 3m, amgen, and s&p 500 we have at t

especially considering how strong amd was. amd is coming on, especially with the acquisition, but nvidia earnings better be strong. i think it's really, really hard to be overwas heading in, especially with how volatile -- we're still long-term holders, but we're watching it closely, and i think the earnings have to be perfect. >> we probably argue that broadcom is up near nvidia. >> should be, 100%, and it's not 100% ai. it's actually been the vmware acquisition, increasing their software exposure. that's recurring revenue with higher margins, but you also get the kick of ai. they think it would be a 30 to 50 billion business for them. they report soon as well, so watching that one very, very closely. >> guys, we'll leave it there. thank you all. >>> let's go to pippa stevens for the biggest names moving into the close. >> j.d.com is falling, according it had been the largest shareholder? jd.com with a 5.19% stake. reuters reports the sales were sold in a price range near 25.85 per share. >>> and texas instruments is gaining

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in the white of the eye. tell your doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. introducing togo's new barbecue beef sandwich. it's piled high with tender beef that's slow cooked and smothered in tangy memphis style barbecue sauce. it's no fuss, no muss. just tons of flavor. the best barbecue beef is only a togo's. try one today. a judge denied bail for 35 year old john jacobo in his first court appearance today. a packed courtroom watched as jacobo pleaded not guilty to four charges, including rape and domestic violence. jacobo is the former director of a powerful housing nonprofit. he resigned earlier this year after our media partner, the san francisco standard, reported on allegations of abuse. at least three women filed police reports over alleged assaults and harassment. jacoba's attorney says he is innocent and they'll fight for his release at his bail hearing, which is set for friday. >>

if you have wet amd, you never want to lose sight of the things you love.e things should stand the test of time. long-lasting eylea hd could significantly improve your vision. more people on eylea hd had no fluid in the retina, compared to those on eylea at 4 months. eylea hd is the only wet amd therapy that helped 8 out of 10 people go up to 4 months between injections, after 3 initial monthly treatments. if you have an eye infection, eye pain or redness or allergies to eylea hd, don't use. eye injections like eylea hd may cause eye infection, separation of the retina, or rare but severe swelling of blood vessels in the eye. an increase in eye pressure has been seen there is an uncommon risk of heart attack or stroke associated with blood clots. the most commons side effects were blurred vision, cataract, corneal injury and eye floaters. and there's still so much to see. if you are on eylea or a similar type of treatment, ask your retina specialist about eylea hd today for the potential for fewer injections. to me, harlem is home. but home is also your bod

amd has been lagging. and chips lately, dan, what do we think about the stock? >> we spent a lot of time speaking of dell's margins in the server business and super micro was last week or two weeks ago had 17% gross margins and just reported 11%. you look at amd with 53% gross margins and say to yourself this might be difficult for them to integrate this, you know, sort of acquisition, this is one of the largest they've ever made and xilinx was bigger than that so to me a low margin business. i'm not sure the verticalization is integral to them building out this platform and having competitive chips that go into the data centers so the market is saying yes right now which i think is interesting but not something that is that importantly incremental. >> carter, looking at the chart there, even with a 4 1/2% gain today, that's pretty much all of it. all of its gains happen today for the most part, carter. what do we think about this chart? >> yeah, i mean 24this is beta. speculating to say the least. to say

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in thewhite of the eye. tell your doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. . >>> now, in its 34th year, jazz summer fest is swinging into san jose's downtown this evening. ♪ >> guess what? that was just the warm up act. the event kicks off this evening and runs through sunday. all tolled, 120 performances and that includes the headliner, herby hancock, the family stone, thousands are expected to attend all over the country. goodwill and people love coming to the festival every year and make traditions out television >> looking forward tottener -- on out of it. >> looking forward to the food and all of the people together. >> and cory henry, and trumpet sensation and a new breed brass band. >>> we are counting down to the 49ers first preseason game tomorrow at 4:00 on kpix5. the red and gold report live from nashville coming up next. thanks so much for watching issue the news continues at 8:0

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in theyour doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. >>> welcome back. here's a live look from our rooftop camera here at kpix in san francisco, giving you a look at a foggy start to the bay. that's the bay bridge treasure island and then off in the distance, the east bay. you can't make it out because of the fog. paul will join us in a few minutes with our weather report. first, excitement is growing for an annual meteor shower. it is expected to peek this weekend, sending streaks of light across our skies, or we see shooting stars and who other than brian hackney, to show us when it's the best time to watch. >> reporter: meet saul garcia, owner of the rock shot. >> i named it after my wife. >> reporter: inside -- >> i do have some stones in here. >> reporter: quite the collection. >> this is a fossil. this is florite. >> did you know about rocks before you bought the shop? >> nothing. >> sa

how about amd? which also makes chips, including chips for that.le not quite as useful for artificial intelligence are still basically in the same league. plus amd makes chips for traditional computing and servers that compete against a hobbled intel. amd's is very cheap. 2026 earnings estimates versus stocks. others in the s&p. oh, and by the way what happened to nvidia was actually good, not bad for amd. they are a competitor, for heaven's sakes. how about a company like apple which is about to issue a new phone that will soon be offering the latest in artificial intelligence for the consumer? the stock's historically pricey but historically apple didn't have a revenue stream that's sticky and prickable and creates a whole new level of stable earnings plus apple will be using chatgpt which has cost openai and microsoft billions of dollars to build yet these guys are getting it for free because apple's such a huge highly valued installed base. how about amazon? down 29 points off its high. even as we've just seen some surprisingly strong numbers f

. >>> shares of amd giving back the 4.5% gains yesterday. it slightly higher right now after revealing plans to buy server builder zt systems for $5 billion. speaking to cnbc yesterday, amd ceo lisa su touting the logic behind the deal. >> zt is really a very strategic acquisition for us. to grow our market open opportunity and penetration in the 400 million tem. there is a lot of opportunity out there. we're at the very, very early innings of this a.i. build out. >> su adds the deal ultimately centered on amd investing for the future. contessa. >> silvana, thank you. >>> let's get to the money movers now. three stock stories of the morning. palo alto is rising after fourth quarter results beat forecast and gave up beat guidance. they bragged about the platform sags -- saying that three times fast. the bundling of products and services and palo alto's ceo talked up the company a.i. services with jim cramer on "mad money" last night. >> along a.i., we are excited. we crossed $200 million in real a.i. and selling products to customers. this is

that may be the amd or other products.they scale out, we are going to see more opportunity come and more spending come in the areas where it's not quite so strong in this room for other players. >>> goldman sachs has analysis indicating that hedge funds and big institutional investors have sold out of big tech. given the outflows there, is the barlower for nvidia with this earnings report? >>. >> you'd think so. i think we've had this conversation around the last couple of quarterly reporting for nvidia. coming back to patience and my soon-to-be 10-year-old. i remember it's like transferring money from the patient to the impatient. you've got a major compute wave where it's only been two years since the launch of chatgpt. we're going to be in strong periods. it won't be a straight line. it won't be linear, but we're starting to see improve points. there are some strong years ahead. we did post the launch of the iphone. that didn't get captured within a couple of years. this is an opportunity to embrace a very new technolog

boar's head deli meat as the death toll rises. e wet amd, you never want to lose sight of the thingsome things should stand the test of time. long-lasting eylea hd could significantly improve your vision. more people on eylea hd had no fluid in the retina, compared to those on eylea at 4 months. eylea hd is the only wet amd therapy that helped 8 out of 10 people go up to 4 months between injections, after 3 initial monthly treatments. if you have an eye infection, eye pain or redness or allergies to eylea hd, don't use. eye injections like eylea hd may cause eye infection, separation of the retina, or rare but severe swelling of blood vessels in the eye. an increase in eye pressure has been seen there is an uncommon risk of heart attack or stroke associated with blood clots. the most commons side effects were blurred vision, cataract, corneal injury and eye floaters. and there's still so much to see. if you are on eylea or a similar type of treatment, ask your retina specialist about eylea hd today for the potential for fewer injections. wanna know a secret? more than just my armpits

. >> they're not competitive in the sense that an nvidia is, or even an amd, in fact they were fightingys ago. it's been a wholesale shift. i don't know. i know jim cramer and carl, and david faber were talking about some analysts questioning whether or not intel could be a going concern. i think that's a bridge too far, but -- >> that tells you how far we have come. >> when you start asking those questions, yeah, it's not good. >> ge has completely broken apart. >> exactly. >>> keith, you want to button this with any thoughts on what you are buying? >> intel is one of these stocks i will stay away from now at all costs, pun actually intended. i went after apple, microsoft, palantir, you know, i'm going to look to some other names that have been hit hard. opportunity is usually made on days like today, you just don't know it until the rear-view mirror. >> keith, one of the questions we talked about, nvidia, and your love for it over the last couple years. is this a moment of doubling down on that? and if you think nvidia at 140, you must love it at 104? >> well, i have no problem buying

eylea hd is the only wet amd therapy that helped 8 out of 10 people go up to 4 months between injectionsy treatments. if you have an eye infection, eye pain or redness or allergies to eylea hd, don't use. eye injections like eylea hd may cause eye infection, separation of the retina, or rare but severe swelling of blood vessels in the eye. an increase in eye pressure has been seen there is an uncommon risk of heart attack or stroke associated with blood clots. the most commons side effects were blurred vision, cataract, corneal injury and eye floaters. and there's still so much to see. if you are on eylea or a similar type of treatment, ask your retina specialist about eylea hd today for the potential for fewer injections. usa, usa, usa, usa, usa. maria: the fraternity brothers of the university of north carolina being rewarded for the active patriotism last spring they defended the american flag from a group of anti-israel protesters trying to deface it. gofundme raised over half a million dollars to throw a party this labor day to celebrate the patriotic group brandon rosenblum held up

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in the of the eye. tell your doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. introducing togo's new barbecue beef sandwich. it's piled high with tender beef that's slow cooked and smothered in tangy memphis style barbecue sauce. it's no fuss, no muss. just tons of flavor. the best barbecue beef is only a togo's. try one today. >>> so a walnut creek bakery owner is caught in the middle of a neighborhood fight over a chick-fil-a. one of the few tenants left in the citrus place shopping center. a chick-fil-a is expected to move into the quiet plaza, but dozens of neighbors have spoken out against the chain, arguing it's going to add traffic and attract a lot of loitering. but one woman welcomes the chick-fil-a. she sees it as a way to boost foot traffic, not just for her business but all the stores in the struggling plaza. she says she's even gotten backlash and even threats to boycott her bakery over

amd's been worse. it's not like amd rallied on that news. so, it gets back to dynamics on, what do you want to pay for this company? we know on a short-term basis, you could put a 25 multiple on it, feel pretty confident, but do you have that out a couple years? i just -- you know, i look at the charts, and everybody says they want to buy nvidia lower, but -- >> here it is. >> yeah. and again, interesting to see where it bounced today. somewhere around $95, $96, you have major support. you have a dynamic here where -- 150 day. are you going to get some places where the markets need to test again lower? one day is not going to do it. and that's why this -- this just isn't a place to be jumping. in just take a pause. >> i bought more today. >> you did? >> i'm long higher. so, i wanted average. i'm not -- i don't have a full position, but i bought more around where it closed. it traded down to $90. if we test the $200, it will be d down. >> everyone is focused on jackson hole what the fed is going to say on august 22nd, i'm focused on nvidia's

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in thef the eye. tell your doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. (noel) did you know it's possible to have a heart attack at age 36? i didn't. here's a tip. if you smoke, it's totally possible. that's what happened to me. (announcer) you can quit. for free help, call 1-800-quit-now. want a next level clean? swish with the whoa of listerine. it kills 99.9% of bad breath germs for five times more cleaning power than brushing and flossing alone. get a next level clean... ahhhhh with listerine. feel the whoa! always dry scoop before you run. listen to me, the hot dog diet got me shredded. it's time we listen to science. one a day is formulated with key nutrients to support whole body health. one a day. science that matters. -incredible, isn't it? -yeah. and with your home, auto, boat, and rv all bundled with progressive, you're free to just enjoy this beautiful view. almost makes everything e

most common side effects are eye discomfort, wet amd, small specks floating in vision, and blood in the of the eye. tell your doctor right away if you have any side effects. every moment counts—act now to slow ga with syfovre. ask your retina specialist about syfovre. if you're frustrated with occasional bloating or gas... your body's giving you signs, it's time to try align. align probiotic was specifically designed by gastroenterologists to help relieve your occasional bloating and gas. when you feel the signs, it's time to try align. (♪♪) is he? claritin clear? yeah. fast relief of allergies with nasal congestion, so you can breathe better. claritin plus decongestant. live claritin clear®. if you have heart failure, entrust your heart to entresto. entresto helps improve your heart's ability to pump blood to the body. don't take entresto if pregnant; it can cause harm or death to an unborn baby. don't take entresto with an ace inhibitor or aliskiren, or if you've had angioedema with an ace or arb. the most serious side effects are angioedema, low blood pressure, kidney problems, or hi